NCT01928238

Brief Summary

The purpose of this study is to compare inspiratory effort, comfort, gas exchange and patient ventilator synchrony during non-invasive neurally adjusted ventilatory assist or pneumatically triggered and cycled-off noninvasive pressure support ventilation (NPSV), in patient at risk of respiratory distress after extubation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2012

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

August 20, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 23, 2013

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2015

Completed
Last Updated

June 25, 2015

Status Verified

January 1, 2015

Enrollment Period

2.3 years

First QC Date

August 20, 2013

Last Update Submit

June 24, 2015

Conditions

Keywords

NIVNAVAnoninvasive neurally adjusted ventilatorynoninvasive pressure support ventilation

Outcome Measures

Primary Outcomes (1)

  • Inspiratory muscle effort

    The primary endpoint variable is the inspiratory muscle effort. To estimate the inspiratory effort, we will determine the transdiaphragmatic pressure (Pdi), the transdiaphragmatic pressure time product per breath (PTPdi/b) or per minute (PTPdi/min) and the Electrical Activity of the Diaphragm (EADI)max.

    At inclusion (day 0)

Secondary Outcomes (3)

  • patient ventilator synchrony

    At inclusion (Day 0)

  • gas exchange

    At inclusion (Day 0)

  • Patient comfort

    At inclusion (Day 0)

Study Arms (2)

Arm 1

EXPERIMENTAL

Patients will have two 20-minute noninvasive periods : Noninvasive neurally adjusted ventilatory assist (NIV-NAVA) and then Noninvasive pressure support ventilation (NPSV)

Device: Noninvasive neurally adjusted ventilatory assist (NIV-NAVA).Device: Noninvasive pressure support ventilation (NPSV)

Arm 2

EXPERIMENTAL

Patients will have two 20-minute noninvasive periods : Noninvasive pressure support ventilation (NPSV) and then Noninvasive neurally adjusted ventilatory assist (NIV-NAVA)

Device: Noninvasive neurally adjusted ventilatory assist (NIV-NAVA).Device: Noninvasive pressure support ventilation (NPSV)

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients intubated for 48 h or more
  • Patients who tolerated a 120-min spontaneous breathing trial after recovery from their acute disease with no signs of respiratory failure
  • Patients at high risk for respiratory after extubation were enrolled if they had at least two of the following risk factors for respiratory failure after extubation:
  • age older than 65 years
  • Chronic obstructive pulmonary disease,
  • heart failure as the cause for intubation
  • An Acute Physiology and Chronic Health Evaluation (APACHE)-II score greater than 12 on the day of extubation.

You may not qualify if:

  • Age younger than 18 years
  • Head trauma or surgery
  • Recent gastric or oesophageal surgery
  • Active upper gastrointestinal bleeding
  • Excessive amount of respiratory secretions
  • Poor cooperation
  • Decision to limit life-supporting treatments in the ICU
  • Tracheostomy or other upper airway disorders
  • Lack of collaboration
  • Do not resuscitate order or any decision to limit therapeutic effort in the ICU.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Bordeaux

Bordeaux, 33000, France

Location

MeSH Terms

Conditions

Acute Lung Injury

Condition Hierarchy (Ancestors)

Lung InjuryLung DiseasesRespiratory Tract Diseases

Study Officials

  • Frédéric VARGAS, MD-PhD

    University Hospital, Bordeaux

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 20, 2013

First Posted

August 23, 2013

Study Start

August 1, 2012

Primary Completion

December 1, 2014

Study Completion

January 1, 2015

Last Updated

June 25, 2015

Record last verified: 2015-01

Locations